Keybank National Association OH Has $21.14 Million Stock Holdings in Aflac Incorporated (NYSE:AFL)

Keybank National Association OH trimmed its position in shares of Aflac Incorporated (NYSE:AFL) by 0.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 204,360 shares of the financial services provider’s stock after selling 1,004 shares during the period. Keybank National Association OH’s holdings in Aflac were worth $21,139,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Commerzbank Aktiengesellschaft FI grew its holdings in shares of Aflac by 332.1% during the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 12,622 shares of the financial services provider’s stock worth $1,300,000 after purchasing an additional 9,701 shares in the last quarter. Synergy Investment Management LLC acquired a new stake in Aflac during the fourth quarter worth $109,000. Charles Schwab Investment Management Inc. increased its holdings in Aflac by 1.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,226,681 shares of the financial services provider’s stock valued at $333,768,000 after buying an additional 47,119 shares during the period. Mission Wealth Management LP increased its holdings in Aflac by 100.2% in the 4th quarter. Mission Wealth Management LP now owns 85,069 shares of the financial services provider’s stock valued at $8,800,000 after buying an additional 42,579 shares during the period. Finally, Fidelis Capital Partners LLC raised its stake in shares of Aflac by 6.1% in the 4th quarter. Fidelis Capital Partners LLC now owns 15,141 shares of the financial services provider’s stock valued at $1,616,000 after buying an additional 876 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of NYSE:AFL opened at $107.56 on Wednesday. The business has a fifty day moving average of $104.79 and a 200-day moving average of $107.67. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a twelve month low of $79.22 and a twelve month high of $115.50. The firm has a market cap of $58.79 billion, a PE ratio of 11.20, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, equities research analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insider Activity at Aflac

In other news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

AFL has been the topic of several recent research reports. Keefe, Bruyette & Woods lowered their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 12th. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. BMO Capital Markets began coverage on Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 target price for the company. Wells Fargo & Company cut their target price on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 19th. Finally, Piper Sandler lowered their price target on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $103.36.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.